(Q53986171)

English

Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

author name string

Hansen JF

1

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

Tingsted L

2

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

Rasmussen V

3

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

Madsen JK

4

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

Jespersen CM

5

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

language of work or name

0 references

publication date

1 June 1996

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

77

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

16

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

16D-21D

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Secondary prevention with verapamil after myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effects of intravenous verapamil on left ventricular relaxation and filling in stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

The influence of verapamil and its isomers on vulnerability to ventricular fibrillation during acute myocardial ischemia and adrenergic stimulation in isolated rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Comparative study of the effect of slow channel inhibiting agents on ischemia-induced conduction delay as relevant to the genesis of ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Calcium antagonists and cardiac noradrenaline release in ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Chronic oral pretreatment with the angiotensin converting enzyme inhibitor, trandolapril decreases ventricular fibrillation in acute ischaemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Ventricular arrhythmias in the acute and chronic phases after acute myocardial infarction. Effect of intervention with captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Systemic and cardiac neuroendocrine activation and severity of myocardial ischemia in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Detection of myocardial ischaemia by transthoracic leads in ambulatory electrocardiographic monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Are right and left ventricular ejection fractions equal? Ejection fractions in normal subjects and in patients with first acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Cross-sectional echocardiography in acute myocardial infarction: detection and localization of regional left ventricular asynergy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

The effect of verapamil on major events in patients with impaired cardiac function recovering from acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

ACE inhibitors after myocardial infarction: patient selection or treatment for all?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Prevalence of transient myocardial ischaemia during the first year after a myocardial infarction. Effect of treatment with verapamil. The Danish Study Group on Verapamil in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Identifiers

10.1016/S0002-9149(96)00303-7

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/8677892

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53986171&oldid=1866544790"